Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 153,122 U.S. patients https://www.medrxiv.org/content/10.1101/2023.01.17.23284689
Systematic analysis of off-label and off-guideline cancer therapy usage in a real-world cohort of 153,122 U.S. patients https://www.medrxiv.org/content/10.1101/2023.01.17.23284689